SRF and neoplasm: Apart from reactivation from latency, UL33 constitutive signalling enhances tumour growth via constitutive activation of the signal transducer and activator of the transcription (STAT)3 proangiogenic pathway to CREB, NF-κB, and serum response factor (SRF) [47].